Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Parkinson's disease according to the standards set by the Movement Disorder Society.
Who may not be able to join:
- People who have clear signs of problems with a part of the brain called the cerebellum, such as a cerebellar-related walking difficulty, poor limb coordination, or certain abnormal eye movements (confirm with trial site)
- People who have difficulty moving their eyes in a downward direction, or whose downward eye movements are noticeably slower than normal
- People who have been diagnosed with a specific type of dementia affecting behaviour, or a condition causing progressive loss of language ability, within the first 5 years of their illness
- People whose Parkinson's-like symptoms have only ever affected the lower half of their body for more than 3 years
- People who are taking medication that blocks or reduces dopamine in a way that could itself be causing their Parkinson's-like symptoms
- People whose symptoms have not responded at all to high doses of a medication called levodopa, despite having a moderate or more severe level of disease
- People who have clear loss of certain types of touch or sensation, difficulty performing purposeful movements with their limbs, or progressive loss of language ability
- People whose brain imaging shows normal results for the dopamine system in a specific area of the brain (confirm with trial site)
- People whose symptoms are more likely explained by a different condition than Parkinson's disease, based on medical records or expert medical assessment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +39 06 3015 5031
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Capacity of the Superior Cervical Ganglion in parkinsonian patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.